Video 2: Diagnosing Alzheimer’s:...

Explore how clinicians use cognitive tests, imaging, and biomarker tools to diagnose Alzheimer’s...

FSSAI Proposes Sugar Restrictions...

FSSAI proposes sugar restrictions in infant foods to protect our...

FDA Recalled Over 4.3...

More than 4.3 million toothpaste tubes have been recalled in...
HomeVIDEOSHow to Treat...

How to Treat Alzheimer’s & Parkinson’s Diseases | Dr. Mark D’Esposito & Dr. Andrew Huberman



Dr. Mark D’Esposito and Dr. Andrew Huberman discuss the complexities and challenges involved in understanding and treating Alzheimer’s disease.

Mark D’Esposito, M.D., is a neurologist and professor of neuroscience and psychology at the University of California, Berkeley. Dr. Andrew Huberman is a tenured professor of neurobiology and ophthalmology at Stanford University School of Medicine and host of the Huberman Lab podcast.

Watch the full episode:
Show notes:

Social & Website
Instagram:
Threads:
X:
Facebook:
TikTok:
LinkedIn:
Website:
Newsletter:

#HubermanLab #Health #Alzheimer

The Huberman Lab podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user’s own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.

source

Continue reading

Video 2: Diagnosing Alzheimer’s: Clinical Criteria and Diagnostic Tools

Explore how clinicians use cognitive tests, imaging, and biomarker tools to diagnose Alzheimer’s accurately and efficiently. Series sponsored by Eisai. To watch the full series, visit aapa.org/VitalRounds References and Additional Resources: Alzheimer’s association statement on first blood test used in diagnosing...

Study defines average human genome and normal genetic disease risk

A new study has characterized the "average" human genome, providing key information on normal human genetic variation and genetic disease risk. Researchers at the University of Exeter...

FSSAI Proposes Sugar Restrictions in Infant Foods: Why It Matters

FSSAI proposes sugar restrictions in infant foods to protect our children's health. Discover why this initiative is crucial for our little ones!